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Summary 
Background: The functional index for hand osteoarthritis (FIHOA), a 10-item investigator-administered questionnaire, was validated in 1995. 
It is relevant, reliable and has good external and internal validities. 
Objective: To assess the sensitivity to change over time of the FIHOA. 
Patients/Methods: Patients: symptomatic [visual analog scale (VAS) _>30 mm, FIHOA _>5] hand OA patients [American College of 
Rheumatology (ACR) criteria, _>2 radiologically affected joints] were included in a 6-month randomized, double-blind, placebo-controlled trial. 
Recorded parameters: Pain on VAS, FIHOA score, morning stiffness duration, grip strength. Statistical analysis: mean standardized 
response (MSR=A D0-M6/s.o of &) was calculated for each parameter in an intention-to-treat (ITT) population before breaking the 
randomization code. 
Resu/ts: 239 women, 22 men, mean age 61 +7.5 years were recruited. Characteristics of HOA: 88% of patients were right-handed, 48% had 
a family history of hand OA. The location of OA was the first trapezo-metacarpal (TMC) joint (62%), proximal interphalangeal (PIP) joint 
(47.5%), distal interphalangeal (DIP) joint (67.6%). The mean number of painful flares (previous 12 months) was 4.4, that of painful joints was 
3.7, that of nodal joints in the right hand 3.1, and that of radiologically affected joints was 4.4. Baseline symptomatic severity assessment 
gave pain on VAS=54.4+14 ram, FIHOA score=10.4+3.7, morning stiffness duration=20+27.6 min and grip strength=59.3±21.2 mm Hg.
The MSR value was 0.58 for the FIHOA and 0.87 for pain on VAS. 
Conc/usion: The sensitivity to change of the FIHOA over 6 months is high, but inferior to that of pain on VAS in this trial. 
© 2000 OsteoArthritis Research Society International 
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Introduction 
Although hand osteoarthritis (HOA) is very common and 
may severely affect a high proportion of people over 50,1 
very few trials have been performed to test the efficacy of 
drugs for this indication 2 (and see Mejjad and Maheu, this 
issue). From the review of the clinical trials performed in 
hand OA, one can easily conclude that the clinical assess- 
ment tools used until now have been generally inaccurate 
and/or irrelevant. 
In 1995 we proposed a functional index for hand OA 
(FIHOA) similar to the current indices used for monitoring 
hip or knee OA. It is a 10-item investigator-administered 
questionnaire using a semi-quantitative assessment 
scoring the disease on a 4-point scale (Table I). 3 This index 
has been validated and conforms to current require- 
ments. 4.s It has shown good metrologic properties: it is 
sensitive and clinically relevant, has good internal validity, 
shows very good consistency and acceptable external 
validity. The FIHOA has good intra-observer eproducibility 
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and is simple to use (2.5 min on average for admin- 
istration). The functional index for hand OA has also 
demonstrated its ability to discriminate between placebo 
and piroxicam ~ and has shown a good interrater eliability, z 
The objective of the present work was to assess the 
sensitivity to change over time of the FIHOA. 
Table I 
Functional index for hand osteoarthritis developed by Dreiser et 
al. a (modified by the authors with the help of Paul Boulos Haraoui) 
1. Are you able to turn a key in a lock? 
2. Are you able to cut meat with a knife? 
3. Are you able to cut cloth or paper with a pair of scissors? 
4. Are you able to lift a full bottle with the hand? 
5. Are you able to clench your fist? 
6. Are you able to tie a knot? 
7. For women: Are you able to sew? 
For men : Are you able to use a screwdriver? 
8. Are you able to fasten buttons? 
9. Are you able to write for a long period of time? 
10. Would you accept a handshake without reluctance? 
Scoring system: 0=poss!ble without difficulty, 1=possible with 
slight difficulty, 2=possible with important difficulty, 3=impossible. 
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Methods and patients 
The FIHOA was selected as one of the efficacy outcome 
criteria in a prospective, randomized, double-blind, 
placebo-controlled trial of 6-month treatment duration, 
conducted to study the efficacy of avocado/soya 
unsaponifiables (ASU) in symptomatic hand OA. 
INCLUSION CRITERIA 
Patients must have fulfilled the ACR criteria for the 
reporting of hand OA, 8 shown X-ray features of hand OA on 
at least two joints on standard plain radiographs of both 
hands, and been symptomatic at entry. The symptom 
severity was defined as pain on a visual analog scale (VAS) 
_>30 mm and a FIHOA score value _>5. In addition to a 
current painful flare, they had to have had at least two 
painful flares in a finger joint during the previous 12 months. 
Excluded from the-trial were patients presenting with a 
monoarticular post-traumatic OA, or any active disease of 
the upper limbs other than digital OA, e.g. scar leading 
to functional disability; Dupuytren's disease; hand (de 
Quervain's), elbow or shoulder tendinitis; carpal tunnel 
(and other neurological tunnel) syndromes or neurologic 
diseases involving the upper limb (lateral amyotrophic 
sclerosis, multiple sclerosis, poliomyelitis); cervicobrachial 
neuralgia; Paget's disease and other osteopathies; articu- 
lar chondrocalcinosis, gout, diabetic hand; inflammatory 
arthritis (psoriatic, rheumatoid arthritis, scleroderma, post- 
gonococcal rheumatism), infectious or tumoral disease; 
recent trauma (previous 2 months); painful sequelae from a 
fracture, luxation or surgery on the upper limb; reflex 
sympathic dystrophy. 
Table II 
Demographic data of 261 patients recruited into the trial 
Parameter 
Sex (%) 22 M (8.4) 239 F (91.6) 
Age (years) 61.1 +7.5 
Weight (kg) 63.7+11.0 
Height (cm) 160.8+6.8 
Age at menopause (years) 48.9±5.4 
Time since menopause (years) 13.3±8.2 
Hormonal replacement 
therapy es/no (%) 95 (43.4) 124 (56.6) 
descriptive parameters could be associated with a change 
of the FIHOA. 
Results 
STUDIED POPULATION 
Two hundred and sixty-one patients entered the trial and 
were considered the I'FI- population. 
DEMOGRAPHIC DATA 
Table II provides the description of the demographic 
data. There were 239 women and 22 men (8.4%), mean 
age 61.1±7.5 years. Mean age at menopause was 
48.9±5.4 years with a time since menopause of 13.3 years 
on average. Of the 219 post-menopausal women, 95 
(43.4%) received a hormone replacement herapy. 
STUDY PARAMETERS 
At baseline, demographic and medical history data 
concerning hand OA and the following symptomatic sever- 
ity parameters were recorded: pain on VAS, FIHOA score, 
morning stiffness duration and grip-strength measurement 
using a sphygmomanometer inflated at 30 mm. These 
clinical outcome measurements were then assessed at 
months 1, 2, 4 and 6. 
STATISTICAL ANALYSIS 
The statistical analysis for this study was done prior to 
breaking the randomization code, on an intention-to-treat 
(I-l-r) basis. Consequently, blinded to the treatment admin- 
istered to the patients, we could not take into account the 
treatment factor in this analysis. 
Demographics, history and data concerning hand OA 
were described. The values of the clinical assessment 
measurements at baseline (DO) and month 6 (M6) were 
recorded and used for the calculation of the mean stand- 
ardized response (MSR) to evaluate the sensitivity to 
change. 9 For those patients who withdrew from the study 
before M6, the last observation carried forward (LOCF) was 
used to estimate the values of the clinical assessment 
parameters at M6. The MSR was calculated as the mean 
difference between DO and M6 values divided by the 
standard deviation of this mean difference: AD0-M6/s.D. 
of A. A multiple stepwise regression analysis was per- 
formed in order to assess whether any of the baseline 
CHARACTERISTICS OF HAND OA (SEE TABLE III) 
Eighty-seven percent of the patients were right-handed. 
Almost half had a maternal history of hand OA. The joints 
affected by OA were the DIP: 69.4%; the first TMC: 61.3%; 
and the PIP: 49.4%. The selected painful joint assessed at 
entry was the first TMC joint in 114 patients, the DIP in 84 
patients, and the PIP in 50 patients. The selected joint was 
on the left side in 65 patients (26.2%). Concerning the 
severity of the disease, patients had a mean of 4.4 painful 
flares during the previous 12 months; they had on average 
3.8 painful joints, 3.1 nodal joints and 4.6 radiologically 
affected joints in the right hand at DO. 
BASELINE SYMPTOM SEVERITY AND MSR 
The values of baseline measurements for each of the 
four clinical assessment tests, the values used for the 
calculation of each MSR and the results are shown in 
Table IV. The symptom severity measurements were as 
expected: 3 10.4+3.7 for the FIHOA score value and 
54.4±14 mm for pain on VAS. Over 6 months, these values 
decreased by 2.8 for the FIHOA score and by 19.5 mm for 
pain on VAS. A decrease in the duration of morning 
stiffness and an improvement of the grip strength were also 
observed. 
The MSR calculations resulted in 0.58 for the FIHOA 
score, 0.87 for pain on VAS, 0.34 and 0.22 respectively 
for morning stiffness duration and grip strength. Multiple 
stepwise regression analysis to try to correlate changes 
in the index score between DO and M6 with individual 
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Table III 
Descriptive data of hand OA in 261 patients 
Parameter 
Handedness right/left: N (%) 
Maternal history of hand OA yes/no (%) 
Location of OA: TMC: N (%) 
PIP 
DIP 
Selected joint at DO for assessment: right/left 
TMC 
PIP 
DIP 
No. of painful flares (previous 12 months) 
No. of painful joints at DO: right hand/left 
No. of joints with node at DO: right hand/left 
No. of radiologically affected joints: right hand/left 
228 (87.4) 33 (12.6) 
127 (48.7) 134 (51.4) 
157 (61.3) 
123 (49.4) 
177 (69.4) 
77/37 
36/14 
69/15 
4.4±5.3 
3.8±2.3/3.1 ±2.3 
3.1 ±1.9/2.4±2.0 
4.6±2.7/4.2±2.9 
TMC: trapezo-metacarpal; PIP: proximal interphalangeal; DIP: distal interphalangeal; D0=day 0. 
Table IV 
Basefine values and mean standardized response (MSR) of the clinical assessment parameters in 261 patients 
Clinical assessment parameter DO M6 AD0-M6 so of A MSR 
mean±so mean±s D 
Functional index for hand OA (FIHOA) 
Global pain on VAS (mm) 
Morning stiffness duration (min) 
Grip strength (mm Hg) 
10.4+3.7 7.6±5.7 -2.8 4.8 0.58 
54.4±14.0 34.9±23.4 -19.5 22.4 0.87 
19.9±27.6 10.7±15.0 -9.2 27.1 0.34 
59.3±21.2 64.2±21.8 4.9 21.8 0.22 
DO: Day 0; M6: month 6; so : standard deviation; A=difference. 
baseline parameters was unsuccessful. The change of the 
FIHOA score correlated only with its own baseline value. 
Discussion 
Despite the fact that hand OA is very common and often 
symptomatic, very few trials to study this condition have 
been performed. However, according to the Osteoarthritis 
Research Society International (OARSI) recommendations, 
the hand is an acceptable model for studying drugs in 
OA. 1° Accurate and relevant clinical tools to study hand OA 
are still needed. One possible tool is the functional index for 
hand OA developed by Dreiser et al. This index has been 
validated for its relevance, reliability, ease of use and ability 
to discriminate between active treatment and placebo. 3'6~ 
The present study was designed to evaluate the 
sensitivity to change of the index during a double-blind, 
placebo-controlled trial of 6-month treatment duration. The 
data extracted from the trial were analysed before the 
randomization code was broken on the global I-I-I- sample. 
One may therefore argue that our results do not take into 
account the effect of treatment in this study. However, the 
sensitivity to change of the FIHOA score was assessed by 
the MSR, i.e. the mean of the differences between DO and 
M6 divided by the standard deviation of the differences. 
This statistical method is currently used to evaluate the 
sensitivity to change of outcome measures. It also allows 
comparison of the sensitivity to change of different tools. 
The results for the FIHOA were compared to those 
obtained for pain rating on VAS, morning stiffness dur- 
ation and grip strength, all commonly used assessment 
parameters in clinical trials of hand OA. 
The patients in this study did not differ from others 
described in previous trials or during the validation process 
of the FIHOA 3'7 except for a higher frequency of CMC OA 
than in prior studies (62%). We do not explain this higher 
prevalence, and in particular do not have data concerning 
the frequency of hypermobility in our study population. 
Since our index is mostly dedicated to the right hand in 
right-handed persons, it may be noticed that 87% of the 
patients were right-handed and that the selected joint at DO 
was on the right hand in 74% of the cases. The baseline 
symptom severity observed was relevant to that required 
in a trial aimed at assessing symptom activity of a drug 
in hand OA. The change observed between DO and M6 
may be related to the time elapsed or to the treatment 
given. 
The MSR value obtained for the FIHOA was 0.58, while 
the MSR for pain rating was 0.87- and 0.34 and 0.22, 
respectively, for the morning stiffness duration and grip- 
strength measurement. One usually considers that if the 
value of the MSR is below 0.4, the sensitivity of the criterion 
is low or very low; between 0.4 and 0.55 to 0.6, the 
sensitivity is medium to high and if over 0.6, the sensitivity 
is very high. 1° Our results show that the sensitivities of both 
morning stiffness duration and grip-strength measurement 
are low, which was anticipated. The sensitivity of pain on 
VAS rating was found to be very high, while the sensitivity 
to change of the FIHOA was found to be high, but inferior to 
that of pain assessment in this study. 
Further analysis of the placebo group should more 
accurately assess the sensitivity to change of the FIHOA. 
Nevertheless, the FIHOA and pain rating on VAS seem to 
be the main criteria to assess the symptomatic activity in 
future hand OA trials, whatever the duration. 
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